JLHL — Jupiter Life Line Hospitals Balance Sheet
0.000.00%
- IN₹88.95bn
- IN₹89.35bn
- IN₹15.00bn
Annual balance sheet for Jupiter Life Line Hospitals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | R2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | PRESS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,061 | 1,359 | 3,181 | 6,021 | 5,439 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 284 | 462 | 639 | 521 | 885 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,804 | 2,093 | 4,098 | 6,925 | 6,849 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,097 | 7,481 | 7,895 | 11,586 | 15,051 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 9,087 | 9,855 | 12,813 | 19,358 | 23,831 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,232 | 1,321 | 1,058 | 1,584 | 2,266 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6,151 | 6,198 | 1,123 | 5,795 | 8,390 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2,936 | 3,657 | 11,690 | 13,562 | 15,441 |
| Total Liabilities & Shareholders' Equity | 9,087 | 9,855 | 12,813 | 19,358 | 23,831 |
| Total Common Shares Outstanding |